Safety and efficacy of ketamine-augmented electroconvulsive therapy in third trimester pregnancy complicated by COVID-19.

Electroconvulsive therapy high-risk pregnancy ketamine major depression suicidal ideation treatment-resistant depression

Journal

Proceedings (Baylor University. Medical Center)
ISSN: 0899-8280
Titre abrégé: Proc (Bayl Univ Med Cent)
Pays: United States
ID NLM: 9302033

Informations de publication

Date de publication:
2022
Historique:
entrez: 28 10 2022
pubmed: 29 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

Major depressive disorder during pregnancy can be detrimental to the fetus and patient. Treatments can include electroconvulsive therapy (ECT) for severe cases. The use of ketamine in ECT can provide symptomatic relief as well as induce anesthesia. Here, we describe the case of a 35-year-old gravid woman with a long-standing history of major depressive disorder who presented with treatment-resistant depression with suicidal ideation after an alteration in her antidepressant medication. After psychiatric evaluation, she was deemed to be a good candidate for ECT augmented with ketamine for symptomatic relief. This was complicated by an positive but asymptomatic COVID-19 status. Despite these factors, the patient experienced significant relief after an eight-treatment course of ECT, with a reduction of her PHQ-9 score from 22/27 to 4/27 points.

Identifiants

pubmed: 36304628
doi: 10.1080/08998280.2022.2106415
pii: 2106415
pmc: PMC9586677
doi:

Types de publication

Case Reports

Langues

eng

Pagination

874-875

Informations de copyright

Copyright © 2022 Baylor University Medical Center.

Références

Brain Sci. 2017 Aug 18;7(8):
pubmed: 28820429
Semin Perinatol. 2015 Nov;39(7):545-7
pubmed: 26428019
Int J Obstet Anesth. 2010 Jan;19(1):71-6
pubmed: 19945846
J Clin Psychiatry. 2021 Mar 16;82(2):
pubmed: 33989464
J Obstet Gynaecol. 2015;35(7):659-62
pubmed: 25526509
Patient Prefer Adherence. 2012;6:369-88
pubmed: 22654508
Anesthesiology. 1986 Feb;64(2):202-5
pubmed: 3946807
Lancet. 1980 Dec 20-27;2(8208-8209):1317-20
pubmed: 6109147
Psychiatry Res. 2005 Nov 15;137(1-2):1-10
pubmed: 16225930
JAMA Intern Med. 2017 Jun 1;177(6):885-887
pubmed: 28418448
Dialogues Clin Neurosci. 2008;10(1):105-17
pubmed: 18472488
Obstet Gynecol. 2004 Apr;103(4):698-709
pubmed: 15051562
Arch Gen Psychiatry. 2010 Oct;67(10):1012-24
pubmed: 20921117
Br J Anaesth. 1979 Dec;51(12):1163-6
pubmed: 526384

Auteurs

Ashmi Patel (A)

Texas A&M College of Medicine, Houston Methodist Hospital, Houston, Texas.

Anna Claire Saucier (AC)

Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas.

Christopher Hobday (C)

Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas.

Ranjit Chacko (R)

Department of Psychiatry, Houston Methodist Hospital, Houston, Texas.

Classifications MeSH